AWM Capital’s Fulgent Genetics FLGT Stock Holding History

AWM Capital’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,000	Closed	-$273K	–	62
2022 Q2	$273K	Hold	5,000	–	–	0.13%	47
2022 Q1	$312K	Hold	5,000	–	–	0.19%	51
2021 Q4	$503K	Hold	5,000	–	–	0.38%	35
2021 Q3	$468K	Buy	+5,000	New	+$454K	0.35%	41

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWM Capital's FLGT Position: Q3 2022 in Review

AWM Capital sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 5,000 shares — an estimated $273K sold.

AWM Capital first reported a position in FLGT in Q3 2021 and held it in 4 quarters. The position peaked at $503K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

AWM Capital reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
AWM Capital sold 5,000 Fulgent Genetics shares in Q3 2022, an estimated $273K.
AWM Capital first reported a position in Fulgent Genetics in Q3 2021 and held it in 4 quarters.
AWM Capital's Fulgent Genetics position peaked at $503K in Q4 2021.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on AWM Capital's 13F filing for Q3 2022, filed 29 Nov 2022.